Compare, Analyse Elder Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   MYLAN
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
MYLAN
Dec-18
ELDER PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3803,382-   
Low Rs1881,861-   
Sales per share (Unadj.) Rs491.21,556.0-  
Earnings per share (Unadj.) Rs-3.242.3-  
Cash flow per share (Unadj.) Rs14.4333.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.51,683.3-  
Shares outstanding (eoy) m20.54514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.61.7 34.3%   
Avg P/E ratio x-89.362.0 -143.9%  
P/CF ratio (eoy) x19.77.9 250.8%  
Price / Book Value ratio x0.81.6 48.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8331,348,698 0.4%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m2,1790-   
Avg. sales/employee Rs ThNM22,872.9-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM621.1-  
INCOME DATA
Net Sales Rs m10,089800,550 1.3%  
Other income Rs m2570-   
Total revenues Rs m10,346800,550 1.3%   
Gross profit Rs m-792207,153 -0.4%  
Depreciation Rs m361149,894 0.2%   
Interest Rs m2,75638,504 7.2%   
Profit before tax Rs m-3,65318,755 -19.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125-2,984 -4.2%   
Profit after tax Rs m-6521,738 -0.3%  
Gross profit margin %-7.825.9 -30.3%  
Effective tax rate %-3.4-15.9 21.5%   
Net profit margin %-0.62.7 -23.9%  
BALANCE SHEET DATA
Current assets Rs m9,240447,026 2.1%   
Current liabilities Rs m9,998325,932 3.1%   
Net working cap to sales %-7.515.1 -49.6%  
Current ratio x0.91.4 67.4%  
Inventory Days Days4684 55.4%  
Debtors Days Days6093 64.2%  
Net fixed assets Rs m10,124155,293 6.5%   
Share capital Rs m206426 48.3%   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,734866,049 0.9%   
Long term debt Rs m4,889934,744 0.5%   
Total assets Rs m22,8822,323,079 1.0%  
Interest coverage x-0.31.5 -21.9%   
Debt to equity ratio x0.61.1 58.6%  
Sales to assets ratio x0.40.3 127.9%   
Return on assets %11.82.6 453.5%  
Return on equity %-0.82.5 -33.7%  
Return on capital %22.33.2 701.7%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,754166,354 7.1%  
From Investments Rs m-561-85,987 0.7%  
From Financial Activity Rs m-6,762-77,498 8.7%  
Net Cashflow Rs m4,4321,378 321.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.04 Rs / USD

Compare ELDER PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: ALKEM LABORATORIES  TTK HEALTHCARE  STRIDES PHARMA SCIENCE  WOCKHARDT  CADILA HEALTHCARE  



Today's Market

Sensex Ends 87 Points Higher; Telecom and Auto Stocks Witness Buying(Closing)

Indian share markets ended their trading session marginally higher. On the sectoral front, gains were seen in the telecom sector and auto sector.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound? (Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS